Bim and PD-1 identify effector CD8 T cells responsive to anti-PD-1 therapy in metastatic melanoma patients

相似書籍

• Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
  由: Vera Aguilera, Jesus, et al.
  出版: (2020)
• T cell Bim levels reflect responses to anti–PD-1 cancer therapy
  由: Dronca, Roxana S., et al.
  出版: (2016)
• Personalized therapy for metastatic melanoma: could timing be everything?
  由: Dronca, Roxana S, et al.
  出版: (2012)
• Role of radiotherapy in extracranial metastatic malignant melanoma in the modern era
  由: Youland, Ryan S., et al.
  出版: (2017)
• CX3CR1 identifies PD-1 therapy–responsive CD8(+) T cells that withstand chemotherapy during cancer chemoimmunotherapy
  由: Yan, Yiyi, et al.
  出版: (2018)